Torey Alling

725 total citations
18 papers, 550 citations indexed

About

Torey Alling is a scholar working on Infectious Diseases, Molecular Biology and Organic Chemistry. According to data from OpenAlex, Torey Alling has authored 18 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 9 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in Torey Alling's work include Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (7 papers) and Cancer therapeutics and mechanisms (6 papers). Torey Alling is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Mycobacterium research and diagnosis (7 papers) and Cancer therapeutics and mechanisms (6 papers). Torey Alling collaborates with scholars based in United States, India and Sweden. Torey Alling's co-authors include Tanya Parish, Mai A. Bailey, Juliane Ollinger, Garrett C. Moraski, Marvin J. Miller, Philip A. Hipskind, Julie V. Early, Allen Casey, Stephanie K. Florio and Jeffrey W. Cramer and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Torey Alling

18 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Torey Alling United States 13 289 265 257 156 49 18 550
Mai A. Bailey United States 13 289 1.0× 264 1.0× 258 1.0× 149 1.0× 45 0.9× 19 541
Jan Madacki France 11 288 1.0× 210 0.8× 165 0.6× 186 1.2× 41 0.8× 14 486
Anne Drumond Villela Brazil 14 260 0.9× 244 0.9× 128 0.5× 142 0.9× 31 0.6× 32 453
O. B. Ryabova Russia 8 329 1.1× 329 1.2× 148 0.6× 149 1.0× 57 1.2× 17 537
Edward Kazyanskaya United States 6 323 1.1× 283 1.1× 120 0.5× 176 1.1× 43 0.9× 7 468
Zuzana Svetlíková Slovakia 8 219 0.8× 316 1.2× 116 0.5× 136 0.9× 31 0.6× 9 464
Kenia Pissinate Brazil 11 148 0.5× 158 0.6× 174 0.7× 74 0.5× 24 0.5× 24 362
Michael Goodwin United States 10 366 1.3× 290 1.1× 153 0.6× 210 1.3× 56 1.1× 14 579
Raghunandan Yendapally United States 10 133 0.5× 232 0.9× 197 0.8× 62 0.4× 24 0.5× 12 435
Stanislav Huszár Slovakia 10 256 0.9× 298 1.1× 169 0.7× 115 0.7× 20 0.4× 12 451

Countries citing papers authored by Torey Alling

Since Specialization
Citations

This map shows the geographic impact of Torey Alling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Torey Alling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Torey Alling more than expected).

Fields of papers citing papers by Torey Alling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Torey Alling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Torey Alling. The network helps show where Torey Alling may publish in the future.

Co-authorship network of co-authors of Torey Alling

This figure shows the co-authorship network connecting the top 25 collaborators of Torey Alling. A scholar is included among the top collaborators of Torey Alling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Torey Alling. Torey Alling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Clark, Damon, et al.. (2020). Laser Tattoo Removal: A New Tool for Hospital-based Violence Prevention?. The American Surgeon. 86(10). 1337–1344. 3 indexed citations
2.
Early, Julie V., Juliane Ollinger, Crystal M. Darby, et al.. (2018). Identification of Compounds with pH-Dependent Bactericidal Activity against Mycobacterium tuberculosis. ACS Infectious Diseases. 5(2). 272–280. 25 indexed citations
3.
O’Malley, Theresa, Torey Alling, Julie V. Early, et al.. (2018). Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels. Antimicrobial Agents and Chemotherapy. 62(6). 43 indexed citations
4.
Files, Megan, Mai A. Bailey, Torey Alling, et al.. (2018). Construction of an overexpression library for Mycobacterium tuberculosis. Biology Methods and Protocols. 3(1). bpy009–bpy009. 9 indexed citations
5.
Odingo, Joshua, Mai A. Bailey, Megan Files, et al.. (2017). In Vitro Evaluation of Novel Nitazoxanide Derivatives against Mycobacterium tuberculosis. ACS Omega. 2(9). 5873–5890. 20 indexed citations
6.
Kesicki, Edward A., Mai A. Bailey, Yulia Ovechkina, et al.. (2016). Synthesis and Evaluation of the 2-Aminothiazoles as Anti-Tubercular Agents. PLoS ONE. 11(5). e0155209–e0155209. 50 indexed citations
7.
Early, Julie V., Allen Casey, A. MARTINEZ‐GRAU, et al.. (2016). Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 60(6). 3608–3616. 25 indexed citations
8.
Alling, Torey, Mai A. Bailey, Aaron Korkegian, et al.. (2015). The 4-aminopiperidine series has limited anti-tubercular and anti-staphylococcus aureus activity. Journal of Negative Results in BioMedicine. 14(1). 4–4. 1 indexed citations
9.
Russo, Francesco, Johan Gising, A.K. Roos, et al.. (2015). Optimization and Evaluation of 5‐Styryl‐Oxathiazol‐2‐one Mycobacterium tuberculosis Proteasome Inhibitors as Potential Antitubercular Agents. ChemistryOpen. 4(3). 342–362. 10 indexed citations
10.
Early, Julie V. & Torey Alling. (2015). Determination of Compound Kill Kinetics Against Mycobacterium tuberculosis. Methods in molecular biology. 1285. 269–279. 10 indexed citations
11.
Alling, Torey, Mai A. Bailey, Megan Files, et al.. (2015). Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity. Journal of Medicinal Chemistry. 58(18). 7273–7285. 34 indexed citations
12.
Odingo, Joshua, Theresa O’Malley, Edward A. Kesicki, et al.. (2014). Synthesis and evaluation of the 2,4-diaminoquinazoline series as anti-tubercular agents. Bioorganic & Medicinal Chemistry. 22(24). 6965–6979. 26 indexed citations
13.
O’Malley, Theresa, Edward A. Kesicki, Torey Alling, et al.. (2014). Bioorganic & Medicinal Chemistry 22 (2014) 6965–6979. 24 indexed citations
14.
Beena, Deepak Kumar, Torey Alling, et al.. (2014). Antibacterial activity of adamantyl substituted cyclohexane diamine derivatives against methicillin resistant Staphylococcus aureus and Mycobacterium tuberculosis. RSC Advances. 4(23). 11962–11962. 14 indexed citations
15.
Bailey, Mai A., Megan Files, Torey Alling, et al.. (2014). Synthesis and anti-tubercular activity of 3-substituted benzo[b]thiophene-1,1-dioxides. PeerJ. 2. e612–e612. 15 indexed citations
16.
Kumar, Deepak, et al.. (2013). Antimycobacterial activity evaluation, time-kill kinetic and 3D-QSAR study of C-(3-aminomethyl-cyclohexyl)-methylamine derivatives. Bioorganic & Medicinal Chemistry Letters. 23(5). 1365–1369. 15 indexed citations
17.
Ollinger, Juliane, Mai A. Bailey, Garrett C. Moraski, et al.. (2013). A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis. PLoS ONE. 8(4). e60531–e60531. 138 indexed citations
18.
Moraski, Garrett C., Lowell D. Markley, Jeffrey W. Cramer, et al.. (2013). Advancement of Imidazo[1,2-a]pyridines with Improved Pharmacokinetics and nM Activity vs. Mycobacterium tuberculosis. ACS Medicinal Chemistry Letters. 4(7). 675–679. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mai A. Bailey Breakdown of academic impact, for papers by Jan Madacki Breakdown of academic impact, for papers by Anne Drumond Villela Breakdown of academic impact, for papers by O. B. Ryabova Breakdown of academic impact, for papers by Edward Kazyanskaya Breakdown of academic impact, for papers by Zuzana Svetlíková Breakdown of academic impact, for papers by Kenia Pissinate Breakdown of academic impact, for papers by Michael Goodwin Breakdown of academic impact, for papers by Raghunandan Yendapally Breakdown of academic impact, for papers by Stanislav Huszár
Rankless by CCL
2026